Jian‐Guang Yu

801 total citations
28 papers, 620 citations indexed

About

Jian‐Guang Yu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Jian‐Guang Yu has authored 28 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Jian‐Guang Yu's work include Heart Rate Variability and Autonomic Control (5 papers), MicroRNA in disease regulation (3 papers) and Muscle and Compartmental Disorders (3 papers). Jian‐Guang Yu is often cited by papers focused on Heart Rate Variability and Autonomic Control (5 papers), MicroRNA in disease regulation (3 papers) and Muscle and Compartmental Disorders (3 papers). Jian‐Guang Yu collaborates with scholars based in China. Jian‐Guang Yu's co-authors include Guojun Cai, Jing Shi, Ding‐Feng Su, Zhen Qin, Bowen Shen, Ling Jiang, Jin‐Min Guo, Liying Zhu, Xiaohui Wang and Xia Liu and has published in prestigious journals such as Chemical Communications, European Heart Journal and European Journal of Pharmacology.

In The Last Decade

Jian‐Guang Yu

27 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jian‐Guang Yu China 14 183 104 84 66 61 28 620
Shung‐Te Kao Taiwan 16 239 1.3× 76 0.7× 45 0.5× 41 0.6× 53 0.9× 30 609
Ke He China 16 284 1.6× 103 1.0× 88 1.0× 89 1.3× 24 0.4× 31 719
Patricia Marchio Spain 9 245 1.3× 100 1.0× 61 0.7× 169 2.6× 52 0.9× 20 833
Sarawut Kumphune Thailand 16 351 1.9× 178 1.7× 63 0.8× 58 0.9× 28 0.5× 70 766
Leila Chodari Iran 16 292 1.6× 55 0.5× 39 0.5× 38 0.6× 80 1.3× 50 829
Rongrong Li China 14 283 1.5× 73 0.7× 144 1.7× 104 1.6× 21 0.3× 37 728
Beidong Chen China 20 349 1.9× 167 1.6× 91 1.1× 153 2.3× 30 0.5× 37 939
Jiazhen Zhu China 18 436 2.4× 145 1.4× 76 0.9× 120 1.8× 100 1.6× 57 1.1k
Baoyi Liu China 14 161 0.9× 42 0.4× 62 0.7× 37 0.6× 25 0.4× 62 614
Lan Li China 13 388 2.1× 202 1.9× 63 0.8× 121 1.8× 37 0.6× 25 908

Countries citing papers authored by Jian‐Guang Yu

Since Specialization
Citations

This map shows the geographic impact of Jian‐Guang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian‐Guang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian‐Guang Yu more than expected).

Fields of papers citing papers by Jian‐Guang Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian‐Guang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian‐Guang Yu. The network helps show where Jian‐Guang Yu may publish in the future.

Co-authorship network of co-authors of Jian‐Guang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jian‐Guang Yu. A scholar is included among the top collaborators of Jian‐Guang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian‐Guang Yu. Jian‐Guang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Jiarong, et al.. (2024). Cardiovascular events in crush syndrome: on-site therapeutic strategies and pharmacological investigations. Frontiers in Pharmacology. 15. 1472971–1472971.
2.
Shen, Bowen, et al.. (2023). Intelligent Bio-FeS-loaded chitosan films with H2O2 rapid response for advanced waterproof and antibacterial food packaging. Food Packaging and Shelf Life. 37. 101083–101083. 44 indexed citations
3.
4.
Wen, Haini, Qingfeng He, Xiaoqiang Xiang, Zheng Jiao, & Jian‐Guang Yu. (2022). Predicting drug-drug interactions with physiologically based pharmacokinetic/pharmacodynamic modelling and optimal dosing of apixaban and rivaroxaban with dronedarone co-administration. Thrombosis Research. 218. 24–34. 13 indexed citations
5.
Wang, Xiaohui, et al.. (2021). Sinomenine in Cardio-Cerebrovascular Diseases: Potential Therapeutic Effects and Pharmacological Evidences. Frontiers in Cardiovascular Medicine. 8. 749113–749113. 30 indexed citations
6.
Wang, Minghui, Jian‐Guang Yu, Lei Cai, & Xiaowei Yang. (2020). Direct reprogramming of mouse fibroblasts into hepatocyte-like cells by polyethyleneimine-modified nanoparticles through epigenetic activation of hepatic transcription factors. Materials Today Chemistry. 17. 100281–100281. 4 indexed citations
7.
Li, Tong, et al.. (2020). Preventive intraperitoneal hyperthermic perfusion chemotherapy for patients with T4 stage colon adenocarcinoma. Techniques in Coloproctology. 25(6). 683–691. 3 indexed citations
8.
Yu, Jian‐Guang, et al.. (2019). Anisodamine Ameliorates Hyperkalemia during Crush Syndrome through Estradiol-Induced Enhancement of Insulin Sensitivity. Frontiers in Pharmacology. 10. 1444–1444. 10 indexed citations
9.
Sun, Yang, Zhen Qin, Jingjing Wan, et al.. (2018). Estrogen weakens muscle endurance via estrogen receptor-p38 MAPK-mediated orosomucoid (ORM) suppression. Experimental & Molecular Medicine. 50(3). e463–e463. 21 indexed citations
10.
Sun, Yang, Dong-ping Xu, Zhen Qin, et al.. (2017). Protective cerebrovascular effects of hydroxysafflor yellow A (HSYA) on ischemic stroke. European Journal of Pharmacology. 818. 604–609. 63 indexed citations
11.
Zhang, Enhui, Miao Wu, Jin‐Min Guo, et al.. (2016). Activation of α7 Nicotinic Acetylcholine Receptor Decreases On-site Mortality in Crush Syndrome through Insulin Signaling-Na/K-ATPase Pathway. Frontiers in Pharmacology. 7. 79–79. 17 indexed citations
12.
Zhang, Ying, et al.. (2016). Sodium Sulfide, a Hydrogen Sulfide‐Releasing Molecule, Attenuates Acute Cerebral Ischemia in Rats. CNS Neuroscience & Therapeutics. 22(7). 625–632. 22 indexed citations
13.
14.
Yu, Jian‐Guang, Enhui Zhang, Aijun Liu, et al.. (2013). Ketanserin improves cardiac performance after myocardial infarction in spontaneously hypertensive rats partially through restoration of baroreflex function. Acta Pharmacologica Sinica. 34(12). 1508–1514. 10 indexed citations
15.
Yu, Jian‐Guang, et al.. (2012). Synergic Effects of Levamlodipine and Bisoprolol on Blood Pressure Reduction and Organ Protection in Spontaneously Hypertensive Rats. CNS Neuroscience & Therapeutics. 18(6). 471–474. 5 indexed citations
16.
Yu, Jian‐Guang, et al.. (2012). N-(2,4-Difluorophenyl)-5-methyl-1,2-oxazole-4-carboxamide hemihydrate. Acta Crystallographica Section E Structure Reports Online. 68(8). o2325–o2325. 1 indexed citations
17.
Yu, Jian‐Guang, Shangqing Song, Hao Shu, et al.. (2011). Baroreflex deficiency hampers angiogenesis after myocardial infarction via acetylcholine- 7-nicotinic ACh receptor in rats. European Heart Journal. 34(30). 2412–2420. 45 indexed citations
18.
Yu, Jian‐Guang, et al.. (2011). From Hypertension to Stroke: Mechanisms and Potential Prevention Strategies. CNS Neuroscience & Therapeutics. 17(5). 577–584. 77 indexed citations
19.
Yu, Jian‐Guang, Jian Wu, Fu‐Ming Shen, et al.. (2008). Arterial Baroreflex Dysfunction Fails to Mimic Parkinson’s Disease in Rats. Journal of Pharmacological Sciences. 108(1). 56–62. 12 indexed citations
20.
Shen, Fu‐Ming, et al.. (2007). KETANSERIN‐INDUCED BAROREFLEX ENHANCEMENT IN SPONTANEOUSLY HYPERTENSIVE RATS DEPENDS ON CENTRAL 5‐HT2A RECEPTORS. Clinical and Experimental Pharmacology and Physiology. 34(8). 702–707. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shung‐Te Kao Breakdown of academic impact, for papers by Ke He Breakdown of academic impact, for papers by Patricia Marchio Breakdown of academic impact, for papers by Sarawut Kumphune Breakdown of academic impact, for papers by Leila Chodari Breakdown of academic impact, for papers by Rongrong Li Breakdown of academic impact, for papers by Beidong Chen Breakdown of academic impact, for papers by Jiazhen Zhu Breakdown of academic impact, for papers by Baoyi Liu Breakdown of academic impact, for papers by Lan Li
Rankless by CCL
2026